Drug approvals slump hits pharmaceutical industry in 2016
The United States approved 22 new medicines last year, the fewest in six years, as FDA rejections increased and companies submitted fewer applications. In 2015 approvals reached 45, the highest in nearly two decades, signaling a shift in innovation, with investors cautious about 2017 amid pressure on prices and uncertain pipeline catalysts.
MENTIONED IN THIS ARTICLE
United States
U.S. Food and Drug Administration
FDA
Also Mentioned on This Page
WELY
At&t Inc
BP PLC
CrownHold
DowChm
DukeEngy
EnPro
John Jn
Krogers
McDnids
Merck
Microsoft
MorgStan
NRG Egg
OcciPet
Oracle
Penney
PepsiCo Pfizer
ProctGam
Qualcom Roydshila
Spdrdutta
S&psodetf Schimbrg
SearsHidgs
SouthnCo
SwstAir
Tenneco
3M Co
TimeWarn
Unilevm
UPS
Ussteel
VerizonCm
WalMart
WalgBoots
WellsFargo
Money&Markets Extra
Vow Jones Indust
Yuy
Donald Trump
Morgan Stanley
Cehance
Amgen
Matthew Perrone
Alex Nieves
Rei
Stoc Technolo
S&p
Eas
Moa
Indeua
Standard & Poor
Barclays Capital
Botter
FED Funds
Fidelity
U.S
Broadmarket Lehman
Moody's
Corp
Lehman
Treasury
iMoneyNet Inc
Houston Methodist
San Jacinto Hospital
Garth Rd
Baytown
Paul C. Redman
M.D
Srcreetta
Reer